Thromboembolic Events During Perioperative Therapy for Resectable and Borderline Resectable Pancreatic Cancer in the PREOPANC-2 Trial

VTE occurred in 9% of patients with (borderline) resectable PDAC undergoing (neo)adjuvant treatment in the year after random assignment and was associated with decreased OS. These results underscore the need for standardized reporting of thromboembolic events in clinical trials and future studies assessing the potential benefits of thromboprophylaxis during neoadjuvant therapy.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2026-01-29
DOI
https://doi.org/10.1200/jco-25-01935
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Thromboembolic Events During Perioperative Therapy for Resectable and Borderline Resectable Pancreatic Cancer in the PREOPANC-2 Trial

Flip M. Kruyt, Roeland De Wilde, S. Bouwense, K. Hermans et al.
Journal of Clinical Oncology
Pancreatic and Hepatic Oncology Research
article

Thromboembolic Events During Perioperative Therapy for Resectable and Borderline Resectable Pancreatic Cancer in the PREOPANC-2 Trial

Flip M. Kruyt, Roeland De Wilde, S. Bouwense, K. Hermans, Suzan Vrijaldenhoven, Judith de Vos‐Geelen, C. Yung Nio, Gijs A. Patijn, Saskia A. C. Luelmo, Leonie J. Mekenkamp, Bo T M Strijbos, Mark R. Roest, G. Patijn, Barbara M. Zonderhuis, Esther N. Dekker, Anouk J. de Wilde, M. B. van der Kolk, Mirte Mayke Streppel, Joost JME Nuyttens, Peter-Paul L.O Coene, Vincent B. Nieuwenhuijs, M. Stommel, O. J. L. Loosveld, Aniek E. van Diepen, Nick van Es, Eva Versteijne, Marjolein Y.V. Homs, Jacob L. van Dam, Marlies L. van Bekkum, Eva M.M. Verkolf, Bas Groot Koerkamp, Bas de Laat, Liselot Valkenburg-van Iersel, Ignace H.J.T. de Hingh, Hugo ten Cate, T.F. Stoop, R.T. Theijse, D. ten Oever, Lieke Brouwer-Hol, J. Sven D. Mieog, Geertjan van Tienhoven, Geert A. Cirkel, Daphne H.M. Droogh, Brigitte C.M. Haberkorn, Nynke Michiels, Jan Willem B. de Groot, Ruth A.L. Willems, Marc G. Besselink, Koop P. Bosscha, Fennie Wit, Quisette P. Janssen, Geert Kazemier, for the Dutch Pancreatic Cancer Group, Olivier R. Busch, Anna M.E. Bruynzeel, Olaf J.L. Loosveld, Johanna W. Wilmink, Misha D.P. Luyer, Hendrik Bos, Laurens V. Beerepoot, Ingmar F. Rompen, Casper H.J. van Eijck, Erwin van der Harst
article en

Abstract

VTE occurred in 9% of patients with (borderline) resectable PDAC undergoing (neo)adjuvant treatment in the year after random assignment and was associated with decreased OS. These results underscore the need for standardized reporting of thromboembolic events in clinical trials and future studies assessing the potential benefits of thromboprophylaxis during neoadjuvant therapy.

Journal of Clinical OncologyVol. 44(8)
Radboud University Nijmegen (NL), Leiden University Medical Center (NL), Maastricht University Medical Centre (NL), Catharina Ziekenhuis (NL), Medisch Spectrum Twente (NL), Erasmus MC (NL), Medisch Centrum Leeuwarden (NL), Radboud University Medical Center (NL), University Medical Center Utrecht (NL), Maastricht University (NL), OLVG (NL), Amsterdam Neuroscience (NL), Maasstad Ziekenhuis (NL), Synapse (Netherlands) (NL), Isala (NL), Erasmus MC Cancer Institute (NL), Amsterdam University Medical Centers (NL), Jeroen Bosch Ziekenhuis (NL), Maastro Clinic (NL), Cancer Center Amsterdam (NL), University of Amsterdam (NL), Erasmus University Rotterdam (NL)
Good health and well-being
Openalex Percentile: Top 74%
Pancreatic and Hepatic Oncology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.